Clomiphene citrate and dexamethazone in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective placebo-controlled study | Zendy

Aboubakr Elnashar | Zendy; Emad Abdelmageed | Zendy; M.R. Fayed | Zendy; Magdy Sharaf | Zendy

Open Access

Clomiphene citrate and dexamethazone in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective placebo-controlled study

Author(s) -

Aboubakr Elnashar,

Emad Abdelmageed,

M.R. Fayed,

Magdy Sharaf

Publication year - 2006

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/del053

Subject(s) - polycystic ovary , ovulation , medicine , pregnancy rate , ovulation induction , infertility , placebo , menstrual cycle , follicular phase , pregnancy , antral follicle , follicle stimulating hormone , clomifene , endocrinology , gynecology , luteinizing hormone , insulin resistance , hormone , biology , insulin , alternative medicine , pathology , genetics

The aim of this work was to evaluate the efficacy of adding dexamethazone (DEX) (high dose, short course) to clomiphene citrate (CC) in CC-resistant polycystic ovary syndrome (PCOS) with normal dehydroepiandrosterone sulphate (DHEAS) in induction of ovulation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research